Erik Domines
No más puestos en curso
Fortuna: 174 $ al 30/04/2024
Perfil
Erik Domines worked as the General Counsel at Recipharm AB from 2014 to 2018 and at Xbrane Biopharma AB from 2021 to 2023.
He completed his undergraduate degree at the University of Stockholm.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0.00% | 31/12/2022 | 8 821 ( 0.00% ) | 174 $ | 30/04/2024 |
Antiguos cargos conocidos de Erik Domines.
| Empresas | Cargo | Fin |
|---|---|---|
| XBRANE BIOPHARMA AB | Consejero General | 01/07/2023 |
| RECIPHARM AB (PUBL) | Consejero General | 31/12/2018 |
Formación de Erik Domines.
| University of Stockholm | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| XBRANE BIOPHARMA AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Erik Domines
